Market closed
Apogee Therapeutics/$APGE
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Apogee Therapeutics
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.
Ticker
$APGE
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
91
Website
APGE Metrics
BasicAdvanced
$2.7B
Market cap
-
P/E ratio
-$2.77
EPS
-
Beta
-
Dividend rate
Price and volume
Market cap
$2.7B
52-week high
$48.85
52-week low
$41.85
Financial strength
Current ratio
16.39
Quick ratio
16.277
Long term debt to equity
1.263
Total debt to equity
1.653
Management effectiveness
Return on assets (TTM)
-18.51%
Return on equity (TTM)
-25.65%
Valuation
Price to book
3.7
Price to tangible book (TTM)
3.7
Price to free cash flow (TTM)
-18.788
Growth
Earnings per share change (TTM)
-43.62%
APGE News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Apogee Therapeutics stock?
Apogee Therapeutics (APGE) has a market cap of $2.7B as of December 23, 2024.
What is the P/E ratio for Apogee Therapeutics stock?
The price to earnings (P/E) ratio for Apogee Therapeutics (APGE) stock is 0 as of December 23, 2024.
Does Apogee Therapeutics stock pay dividends?
No, Apogee Therapeutics (APGE) stock does not pay dividends to its shareholders as of December 23, 2024.
When is the next Apogee Therapeutics dividend payment date?
Apogee Therapeutics (APGE) stock does not pay dividends to its shareholders.
What is the beta indicator for Apogee Therapeutics?
Apogee Therapeutics (APGE) does not currently have a Beta indicator.